To further explore the association between GRK3 and clinical progression of colon cancer, the immunohistochemistry study was introduced to detect GRK3 expression in a total of 180 cases of primary colon cancer paired with noncancerous samples from two independent tissue microarray (TMA). Here, GRK3 is linked to colonic neoplasm.